Novel biomarkers for diagnosis and monitoring of immune thrombocytopenia

A Allegra, N Cicero, G Mirabile, CM Giorgianni… - International journal of …, 2023 - mdpi.com
Lower-than-normal platelet counts are a hallmark of the acquired autoimmune illness known
as immune thrombocytopenia, which can affect both adults and children. Immune …

Chlorogenic acid compounds from sweetpotato (Ipomoea batatas L.) leaves facilitate megakaryocyte differentiation and thrombocytopoiesis via PI3K/AKT pathway

Y Zhang, L Zhao, L Wang, R Yue, H Zhu… - Frontiers in …, 2024 - frontiersin.org
Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by
antiplatelet autoantibodies, thrombocytopenia, and bleeding, however, its treatment options …

Obesity is associated with adverse outcomes in primary immune thrombocytopenia-a retrospective single-center study

Z Xiao, Z He, HLL Nguyen, RK Thakur… - Annals of …, 2024 - Springer
The pathophysiology of immune thrombocytopenia (ITP) involves immune-mediated platelet
destruction. The presence of adipose tissue in obese individuals creates an inflammatory …

Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a …

J Su, M Xu, Z Dong, Q Wang, L Ma, P Xiao, X Chen - Hematology, 2023 - Taylor & Francis
ABSTRACT Objective: Antinuclear antibody (ANA)-positive immune thrombocytopenia (ITP)
patients have an unsatisfactory prognosis due to the more severe conditions of these …

[PDF][PDF] Updates of Pathogenesis, Diagnosis, and Treatment of Immune Thrombocytopenia

M Naser, MM Nasr, LH Shehata - 2024 - researchgate.net
Primary immune thrombocytopenia is an autoimmune disorder associated with a decreased
prephiral blood platelet count. The phenotype is variable with a few instances struggling no …

Frequency and Clinical Significance of Antinuclear Antibody Positivity in Immune Thrombocytopenia in Adults

R Munawar Ali, S Zafar, M Abid, A Javed Butt… - …, 2023 - journals.sagepub.com
Background Immune thrombocytopenia is an immune-mediated disorder with heterogenous
presentation. It shows association with other autoimmune disorders with varying frequency …

[HTML][HTML] Predictive factors of response to eltrombopag and romiplostim in Egyptian immune thrombocytopenia patients: a single center experience

D El Demerdash, N Mohamady… - The Egyptian Journal …, 2023 - journals.lww.com
Background Thrombopoietin receptor agonists (TPO-RA) are a well-established treatment in
patients with immune thrombocytopenia (ITP). Predictors of response to some lines of …

Efficacy of hydroxychloroquine in children with chronic immune thrombocytopenia and its association with ANA positivity

L Zhang - Authorea Preprints, 2024 - authorea.com
Background Study on the effect of hydroxychloroquine (HCQ) in treating children with
chronic immune thrombocytopenia (ITP) is limited. The association between ANA positivity …

[PDF][PDF] Khảo sát đặc điểm lâm sàng, sinh học, đáp ứng điều trị ở bệnh nhân giảm tiểu cầu miễn dịch người lớn có xét nghiệm ANA tại Bệnh viện Chợ Rẫy= Effect of …

TH Vy, HT Võ, TNS Nguyễn, MCB Suzanne, TT Trần - 2022 - thuvienlamdong.org.vn
Giảm tiểu cầu miễn dịch (GTCMD) là bệnh lý huyết học mắc phải thường gặp, có tỉ lệ hiện
diện kháng thể kháng nhân (ANA) liên quan đến các rối loạn tự miễn. Nghiên cứu đánh giá …

[引用][C] Successful avatrombopag salvage treatment in a pediatric patient with ANA‐positive refractory thrombocytopenia

D Turudic, D Zupan, DT Perkovic, D Zima… - Pediatric Blood & …, 2024 - Wiley Online Library